Optometric Education Consultants
  • About OEC
  • Case Challenge
  • Conferences
    • Nashville 2023
    • Scottsdale 2024
    • Pittsburgh 2024
    • Sarasota 2024
    • Barcelona 2024
    • Disney Resort 2024
    • Quebec 2024
    • Nashville 2024
    • Mackinac Island Recap
    • Germany Recap
    • Orlando Recap
    • All Conference Recaps
  • Webinars
  • Enduring Learning
  • YouTube & Resources
Select Page

TQ Course | Hot Topics in Retina (Sarasota 2023)

by Innereactive | Mar 6, 2023 | 2023 Sarasota, TQ Courses | 0 comments

"*" indicates required fields

Hidden

Hot Topics in Retina

Hidden
MM slash DD slash YYYY
Hidden
MM slash DD slash YYYY
Hidden
MM slash DD slash YYYY
Hidden
1. Most drugs are currently listed as Pregnancy category ______, which means that “there are no studies in animals or humans”.*
2. Which level of diabetic retinopathy does level #47 fall into?*
3. Which diagnostic test below is the most sensitive for detecting fluid in the retina*
4. What is considered to be the number one risk factor for the development of AMD?*
5. According to recent studies what is the earliest level of diabetic retinopathy that treatment is being considered?*
6. What does OCT stand for?*
7. What would not be a reasonable option for managing dry AMD?*
8. What was the sensitivity for the 1st FDA approved AI device in diagnosing more than moderate NPDR?*
9. What is NOT a term used to described diabetes-related macular edema?*
10. Which technology below allows visualization of the retinal vasculature by capturing motion?*
11. Which drug is the first bi-specific antibody for intraocular use?*
12. By year 2050 what is the estimated prevalence of diabetes in the US population?*
13. Which one of the following is considered to be the most significant risk factor for the development of AMD?*
14. Which FDA approved anti-VEGF drug is considered to have the longest duration of action and will result in less frequent injections?*
15. Which new innovative technology allows patients to take home a device that allows the greatest potential to help diagnose wet CNV earlier than ever before?*
16. Which has emerged as the treatment of choice for macular edema associated with diabetic macular edema?*
17. Which drug treatment for Wet AMD resulted in a number of cases near blinding inflammatory retinal vasculitits shortly after FDA approval?*
18. Which drug company has an approved port drug delivery system for treating AMD?*
19. Which hereditary retinal disease was the first to be treated with gene therapy*
20. According to an ARVO position statement, how often should an OCT be performed in patients over the age of 60?*

Personal Information

Name*
Address*

Payment Information

Hidden
After 5/5/2023, pricing will increase to $30.
This course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30.
Paying Via Credit Card A Paypal account is not required to pay using the button below. To pay using a credit card, click the Paypal button below. A new window will appear and a button "Pay with Debit or Credit Card" is available at the bottom of that window for your convenience. 
Payment Method
MasterCard
Visa
Supported Credit Cards: MasterCard, Visa
 
Hidden

Course Information (HIDDEN)

Hidden
Hidden
Hidden
Do not include ending backslash (aka no .com/)
Hidden

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Upcoming Conferences

Ready to get away this summer or fall. View our upcoming conferences and register today!

View Events

Case Challenges

Case Challenges

View our library of case challenges and share your comments or questions in the comment box below!

Learn More
For questions and more information, please contact us at events@optometricedu.com

Like and follow us on Facebook, Twitter, and Instagram for conference updates!

Subscribe For Event Updates

* indicates required